Patents by Inventor Guillemette Duchateau-Nguyen

Guillemette Duchateau-Nguyen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers and methods for progression prediction for chronic kidney disease
    Patent number: 10274502
    Abstract: Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: April 30, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Maria Bobadilla, Laura Badi, Guillemette Duchateau-Nguyen, Laurent Essioux, Hanno Langen, Maria Chiara Magnone, Thomas Schindler, Martina Thier, Ivan Formentini, Gonzalo Christian Duran Pacheco, Corinne Solier, Matthias Kretzler, Viji Nair, Ju Wenju
  • BIOMARKERS AND METHODS FOR PROGRESSION PREDICTION FOR CHRONIC KIDNEY DISEASE
    Publication number: 20160320410
    Abstract: Subject of the present invention are biomarkers and methods for the identification of an increased risk of the progression of chronic kidney disease (CKD), or for monitoring chronic kidney disease therapy, comprising the detecting the level of one or more of NTpro BNP, EGF, Apo H, GDF-15, and albumin-to-creatinine ratio.
    Type: Application
    Filed: October 31, 2014
    Publication date: November 3, 2016
    Inventors: Maria BOBADILLA, Laura BADI, Guillemette DUCHATEAU-NGUYEN, Laurent ESSIOUX, Hanno LANGEN, Maria Chiara MAGNONE, Thomas SCHINDLER, Martina THIER, Ivan FORMENTINI, Gonzalo Christian DURAN PACHECO, Corinne SOLIER, Matthias KRETZLER, Viji NAIR, JU Wenju
  • CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) BIOMARKERS
    Publication number: 20140017230
    Abstract: The present application describes chronic lymphocytic leukemia (CLL) biomarkers. In particular, the invention concerns miRNA151 3p, miRNA409 3p, PTK2, and/or PI3K as biomarkers for patient selection in CLL, as well as methods of therapeutic treatment, articles of manufacture and methods for making them, diagnostic kits, and methods of advertising related thereto.
    Type: Application
    Filed: February 1, 2013
    Publication date: January 16, 2014
    Applicants: HOFFMANN-LA ROCHE INC., GENENTECH, INC.
    Inventors: DAVID DORNAN, GUILLEMETTE DUCHATEAU-NGUYEN, TRI QUANG NGUYEN, GIUSEPPE PALERMO, MARTIN WEISSER, RU-FANG YEH
  • METHODS FOR DETECTING LOW GRADE INFLAMMATION
    Publication number: 20120164639
    Abstract: The present invention relates to methods for detecting the presence of low grade inflammation in a patient.
    Type: Application
    Filed: November 23, 2011
    Publication date: June 28, 2012
    Inventors: MARIA BOBADILLA, PAUL DELMAR, GUILLEMETTE DUCHATEAU-NGUYEN, STANLEY LAZIC, MARIA CHIARA MAGNONE, TRI QUANG NGUYEN
  • IPP COMPLEX AS MARKER FOR ERLOTINIB TREATMENT
    Publication number: 20120095029
    Abstract: The present invention provides biomarkers which are predictive for the clinical benefit of erlotinib hydrochloride treatment in cancer patients.
    Type: Application
    Filed: October 11, 2011
    Publication date: April 19, 2012
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Angélique Augustin, Guillemette Duchateau-Nguyen, Laurent Essioux, Sabrina Golling, Barbara Klughammer, Jens Lamerz, Hanno Langen, Héléne Meistermann, Stefan Scheiblich, Manuel Tzouros
  • AZGP Gene Single Nucleotide Polymorphisms (SNPs)
    Publication number: 20100086912
    Abstract: The present invention provides single nucleotide polymorphisms and haplotypes in the AZGP1 gene that can be used for determining the predisposition of an individual to obesity.
    Type: Application
    Filed: November 9, 2006
    Publication date: April 8, 2010
    Inventors: Roger G. Clerc, Guillemette Duchateau-Nguyen, Laurent Essioux, Delphine Lagarde, Claes-Goran Ostenson
  • Screening assays
    Publication number: 20050158771
    Abstract: The present invention relates to novel gene and polypeptide targets identified in skeletal muscle for screening of compounds that may be useful for the prevention and treatment of obesity.
    Type: Application
    Filed: December 22, 2004
    Publication date: July 21, 2005
    Inventors: Roger Clerc, Guillemette Duchateau-Nguyen, Christophe Gardes, Jacques Mizrahi, Claes-Goran Ostenson
  • Screening assays
    Publication number: 20050136465
    Abstract: The present invention relates to novel targets for identifying compounds that may be useful for the prevention and treatment of obesity.
    Type: Application
    Filed: December 22, 2004
    Publication date: June 23, 2005
    Inventors: Roger Clerc, Guillemette Duchateau-Nguyen, Christophe Gardes, Jacques Mizrahi, Claes-Goran Ostenson